Literature DB >> 3891335

New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections.

S J Cryz.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 3891335     DOI: 10.1007/bf02013588

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  33 in total

1.  Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.

Authors:  B H Iglewski; J Sadoff; M J Bjorn; E S Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen.

Authors:  A Kimura; P A Gulig; G H McCracken; T A Loftus; E J Hansen
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

3.  Survival of Pseudomonas aeruginosa in the hospital environment.

Authors:  V Hurst; V L Sutter
Journal:  J Infect Dis       Date:  1966-04       Impact factor: 5.226

4.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

5.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.

Authors:  S J Cryz; T L Pitt; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

7.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone.

Authors:  S E Greisman; J B DuBuy; C L Woodward
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

Review 9.  Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.

Authors:  C S Bryan; K L Reynolds; E R Brenner
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

10.  Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.

Authors:  O R Pavlovskis; D C Edman; S H Leppla; B Wretlind; L R Lewis; K E Martin
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.609

View more
  2 in total

1.  Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs.

Authors:  W Seeger; D Walmrath; H Neuhof; F Lutz
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

2.  Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.

Authors:  R C Matthews; J P Burnie; S Tabaqchali
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.